Mukka Proteins to hold 16th AGM on Sep 10, 2026, via Video Conference
Mukka Proteins Limited will conduct its 16th Annual General Meeting on September 10, 2026, at 3:00 PM IST via Video Conference. E-voting will be open from September 7 to September 9, 2026. The cut-off date for voting eligibility is September 3, 2026.
This is a standard corporate compliance announcement regarding the scheduling of the AGM and e-voting. It does not involve any material changes to the company's business, financials, or strategic direction.
The announcement is a routine intimation about the Annual General Meeting and does not contain any financial or operational updates that would suggest a positive or negative sentiment.
Mukka Proteins Limited has announced that its 16th Annual General Meeting (AGM) will be held on Thursday, September 10, 2026, at 03:00 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OA VM) facility, without the physical presence of members. The company has published this information in Business Standard (English) and Vijaya Karnataka (Kannada) newspapers on August 19, 2026.
Members will have the facility to cast their votes on all resolutions through remote e-voting or e-voting during the AGM. The cut-off date for determining eligibility to vote is Thursday, September 3, 2026. The remote e-voting period will commence on Monday, September 7, 2026, at 9:00 a.m. (IST) and conclude on Wednesday, September 9, 2026, at 5:00 p.m. (IST). Central Depository Services (India) Limited (CDSL) has been appointed to provide VC/OA VM services and the e-voting facility.
The Notice of the 16th AGM, along with the Annual Report for the financial year 2025-26, has been made available on the company's website (www.mukkaproteins.com) and the websites of BSE Limited (www.bseindia.com), National Stock Exchange of India Limited (www.nseindia.com), and CDSL (www.evotingindia.com). Electronic dispatch of the Notice and Annual Report was completed on Tuesday, August 18, 2026, to members whose email addresses are registered.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.